OEGSTGEEST, Netherlands, July 13, 2021 /PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, announces the closing of a EUR 26 million funding round with participation from new investors including Invest-NL and existing investors including Regeneron. The...
from PR Newswire: https://ift.tt/3yRwK3n
No comments:
Post a Comment